 |
|
Longitudinal Cognitive and Motor Changes Among Presymptomatic Huntington Disease Gene Carriers
Sandra Close Kirkwood, MS;
Eric Siemers, MD;
Julie C. Stout, PhD;
M. E. Hodes, MD, PhD;
P. Michael Conneally, PhD;
Joe C. Christian, MD, PhD;
Tatiana Foroud, PhD
Arch Neurol. 1999;56:563-568.
Objective To determine whether longitudinal changes in cognitive and motor function can be detected among clinically presymptomatic individuals carrying the Huntington disease (HD) allele.
Design A longitudinal, case-control, double-blind study comparing presymptomatic gene carriers and non–gene carriers at risk for HD examined an average of 3.7 years apart.
Setting The Department of Medical and Molecular Genetics at a general clinic research center in Indianapolis, Ind.
Participants A sample of 43 at-risk individuals consisting of presymptomatic gene carriers (n=12) and non–gene carriers (n=31).
Measures Huntington disease gene status was determined by molecular testing of the HD gene. Subscales from the Wechsler Adult Intelligence Scale–Revised and a quantified neurologic rating scale were administered.
Results Scores on the digit symbol subscale of the Wechsler Adult Intelligence Scale–Revised (P<.05) and 2 neurologic variables—optokinetic nystagmus (P<.01) and rapid alternating movements (P<.005)—declined more rapidly among presymptomatic gene carriers than among non–gene carriers. At follow-up examination, compared with non–gene carriers, presymptomatic gene carriers had significantly lower scores on the digit symbol subscale (P=.02) and for 4 neurologic variables—rapid alternating movements (P<.005), optokinetic nystagmus (P<.001), overall ocular movements (P<.02), and chorea of the trunk (P<.02).
Conclusions Psychomotor speed, optokinetic nystagmus, and rapid alternating movements demonstrated significant decline early in the pathological process of HD. These results suggest that subtle worsening of psychomotor, oculomotor, and motor functions occurs before the onset of signs sufficient to make a clinical diagnosis in individuals who have inherited the HD allele.
From the Departments of Medical and Molecular Genetics (Ms Kirkwood and Drs Hodes, Conneally, Christian, and Foroud) and Neurology (Drs Siemers and Conneally), Indiana University School of Medicine, Indianapolis; and the Department of Psychology, Indiana University, Bloomington (Dr Stout).
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(5):634-636.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Paulsen et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:874-880.
ABSTRACT
| FULL TEXT
Longitudinal Evaluation of "Presymptomatic" Carriers of Huntington's Disease
Witjes-Ane et al.
J. Neuropsychiatry Clin. Neurosi. 2007;19:310-317.
ABSTRACT
| FULL TEXT
Predictors of diagnosis in Huntington disease
Langbehn et al.
Neurology 2007;68:1710-1717.
ABSTRACT
| FULL TEXT
Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study
Kipps et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:650-655.
ABSTRACT
| FULL TEXT
Deficits in Experience-Dependent Cortical Plasticity and Sensory-Discrimination Learning in Presymptomatic Huntington's Disease Mice
Mazarakis et al.
J. Neurosci. 2005;25:3059-3066.
ABSTRACT
| FULL TEXT
Huntington's Disease: Phenomenological Diversity of a Neuropsychiatric Condition That Challenges Traditional Concepts in Neurology and Psychiatry
Tost et al.
Am. J. Psychiatry 2004;161:28-34.
FULL TEXT
Cognitive and Motor Functioning in Gene Carriers for Huntington's Disease: A Baseline Study
Witjes-Ane et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:7-16.
ABSTRACT
| FULL TEXT
Behavioural complaints in participants who underwent predictive testing for Huntington's disease
Witjes-Ane et al.
J. Med. Genet. 2002;39:857-862.
FULL TEXT
Effects of Depression on Working Memory in Presymptomatic Huntington's Disease
Nehl et al.
J. Neuropsychiatry Clin. Neurosi. 2001;13:342-346.
ABSTRACT
| FULL TEXT
Progression of Symptoms in the Early and Middle Stages of Huntington Disease
Kirkwood et al.
Arch Neurol 2001;58:273-278.
ABSTRACT
| FULL TEXT
Subtle changes among presymptomatic carriers of the Huntington's disease gene
Kirkwood et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:773-779.
ABSTRACT
| FULL TEXT
Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p
Byrne et al.
Neurology 2000;54:1510-1517.
ABSTRACT
| FULL TEXT
|
